CN104163755B - A kind of method preparing magnolol and Honokiol from Leaf of Magnolia officinalis - Google Patents
A kind of method preparing magnolol and Honokiol from Leaf of Magnolia officinalis Download PDFInfo
- Publication number
- CN104163755B CN104163755B CN201410386682.4A CN201410386682A CN104163755B CN 104163755 B CN104163755 B CN 104163755B CN 201410386682 A CN201410386682 A CN 201410386682A CN 104163755 B CN104163755 B CN 104163755B
- Authority
- CN
- China
- Prior art keywords
- magnolol
- honokiol
- acetone
- methanol
- magnolia officinalis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 title claims abstract description 140
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 title claims abstract description 44
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 22
- 241001673966 Magnolia officinalis Species 0.000 title claims description 46
- 238000000926 separation method Methods 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 15
- 239000011347 resin Substances 0.000 claims abstract description 14
- 229920005989 resin Polymers 0.000 claims abstract description 14
- 239000011148 porous material Substances 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 11
- 239000000178 monomer Substances 0.000 claims abstract description 8
- 238000002425 crystallisation Methods 0.000 claims abstract description 4
- 230000008025 crystallization Effects 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 96
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 60
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 41
- 239000000284 extract Substances 0.000 claims description 28
- 239000000243 solution Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 21
- 238000010992 reflux Methods 0.000 claims description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000000741 silica gel Substances 0.000 claims description 15
- 229910002027 silica gel Inorganic materials 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 239000000523 sample Substances 0.000 claims description 13
- 239000003208 petroleum Substances 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 7
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 7
- 239000012488 sample solution Substances 0.000 claims description 7
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Natural products CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 5
- 241000218378 Magnolia Species 0.000 abstract description 4
- 238000003912 environmental pollution Methods 0.000 abstract description 3
- 239000003960 organic solvent Substances 0.000 abstract description 3
- 238000000638 solvent extraction Methods 0.000 abstract description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 1
- 238000004440 column chromatography Methods 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 229940125782 compound 2 Drugs 0.000 description 8
- 239000000287 crude extract Substances 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 239000012141 concentrate Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 239000002249 anxiolytic agent Substances 0.000 description 2
- 230000003293 cardioprotective effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/004—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by obtaining phenols from plant material or from animal material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种从厚朴叶中制备厚朴酚及和厚朴酚的方法,属于中药现代化领域。一种从厚朴叶中制备厚朴酚及和厚朴酚的方法,应用有机溶剂提取、小孔径树脂分离制备、有机溶剂结晶等方法从厚朴叶中制备高纯度厚朴酚及和厚朴酚单体成分,与现有的有工艺方法相比,具有工艺简单、粗提溶剂成本低、柱层析陈本低、填料分离精度高可反复利用,层析溶剂成本低、对环境污染相对较轻、厚朴酚及和厚朴酚纯度高等优点,适合工业型制备。
The invention relates to a method for preparing magnolol and honokiol from magnolia leaves, belonging to the field of traditional Chinese medicine modernization. A method for preparing magnolol and honokiol from magnolia leaves, using methods such as organic solvent extraction, small-pore resin separation preparation, and organic solvent crystallization to prepare high-purity magnolol and honokiol from magnolo leaves Compared with the existing technological methods, the phenol monomer component has the advantages of simple process, low cost of crude extraction solvent, low cost of column chromatography, high separation precision of packing, reusable, low cost of chromatographic solvent, and relative environmental pollution. It has the advantages of light weight, high purity of magnolol and honokiol, and is suitable for industrial preparation.
Description
技术领域technical field
本发明涉及一种从厚朴叶中制备厚朴酚(Magnolol)及和厚朴酚(Honokiol)的方法,属于中药现代化领域。The invention relates to a method for preparing magnolol (Magnolol) and honokiol (Honokiol) from magnolia leaves, belonging to the field of traditional Chinese medicine modernization.
背景技术Background technique
厚朴酚及和厚朴酚为同分异构体,二者为常用中药厚朴的抗菌活性成分,同时也是厚朴药材质量控制的主要指标成分。文献报道二者除了抗菌作用外,还具有抗炎、抗焦虑、抗抑郁、抗肿瘤、抗衰老和心肌保护作用;此外,还有明显的、持久的中枢性肌肉松弛和中枢神经抑制作用;近期有药效学研究证实,厚朴酚及和厚朴酚还显示出降血糖活性。Magnolol and honokiol are isomers, and they are the antibacterial active components of Magnolia officinalis commonly used in traditional Chinese medicine, and they are also the main index components of the quality control of Magnolia officinalis. It has been reported in the literature that in addition to antibacterial effects, the two also have anti-inflammatory, anti-anxiety, anti-depressant, anti-tumor, anti-aging and cardioprotective effects; in addition, there are obvious and long-lasting central muscle relaxation and central nervous inhibition effects; recently Pharmacodynamic studies have confirmed that magnolol and honokiol also exhibit hypoglycemic activity.
厚朴为常用中药,来源于木兰科木兰属植物厚朴Magnolia officinalis Rehd et Wils.和凹叶厚朴Magnolia officinalis Rehd.et Wils.var.biloba Rehd.et Wils.的干燥干皮、枝皮和根皮,主产于四川、湖北、浙江、福建和安徽等地,具有芳香化湿、行气消积、燥湿除满、降逆平喘的功效,主治食积气滞、腹胀便秘、湿阻中焦、脘痞吐泻、痰壅气逆、胸满喘咳等病症。许多常用处方和中成药制剂中都有厚朴入药。Magnolia officinalis is a commonly used traditional Chinese medicine, derived from the dried dry bark, branch bark and root bark of Magnolia officinalis Rehd et Wils. and Magnolia officinalis Rehd.et Wils.var.biloba Rehd.et Wils. It is mainly produced in Sichuan, Hubei, Zhejiang, Fujian, Anhui and other places. It has the effects of aromatizing dampness, promoting qi and eliminating accumulation, drying dampness and eliminating fullness, reducing adverse events and relieving asthma. Symptoms such as abdominal distension, vomiting and diarrhea, phlegm stagnation and qi reversal, chest fullness, wheezing and coughing. Magnolia officinalis is used as medicine in many commonly used prescriptions and Chinese patent medicine preparations.
随着厚朴药材应用范围的扩大,其需求量在不断增加,为满足对其不断增大的需求量,目前已在四川、湖北、浙江、福建等主产区建立厚朴药材生产基地,大力发展厚朴种植。据初步统计,全国种植厚朴和凹叶厚朴面积不少于70万亩,栽培厚朴林多为厚朴纯林,每亩栽培厚朴约200~300株,以每株树每年平均产厚朴干叶1.5~2.5kg计算,全国厚朴叶的蕴藏量每年可达30万吨以上。厚朴为落叶乔木,其叶长25~50cm,宽15~25cm,11月自然凋落,来年春天又发新叶,因此,厚朴叶获取方式简便,资源丰富且每年可以再生。目前,国内大量厚朴叶未加利用,任其凋落腐烂,如能开发利用为新药材,不仅有利于厚朴资源的综合利用,而且可产生较大的经济效益和社会效益,对退耕还林和药农增收也起到一定的支持作用。With the expansion of the application range of magnolia officinalis, its demand is constantly increasing. In order to meet the increasing demand, magnolia officinalis production bases have been established in major production areas such as Sichuan, Hubei, Zhejiang, and Fujian. Develop Magnolia officinalis planting. According to preliminary statistics, the area of Magnolia officinalis and Magnolia officinalis planted in the country is not less than 700,000 mu, and most of the cultivated Magnolia officinalis forests are pure Magnolia officinalis forests, with about 200 to 300 Magnolia officinalis cultivated per mu, and the average annual dry leaves of Magnolia officinalis per tree Calculated at 1.5-2.5kg, the reserve of Magnolia officinalis in the whole country can reach more than 300,000 tons per year. Magnolia officinalis is a deciduous tree. Its leaves are 25-50cm long and 15-25cm wide. They will naturally wither in November and produce new leaves in the next spring. Therefore, Magnolia officinalis leaves are easy to obtain, rich in resources and can be regenerated every year. At present, a large number of Magnolia officinalis leaves are not utilized in China, and they are allowed to fall and rot. If they can be developed and utilized as new medicinal materials, it will not only benefit the comprehensive utilization of Magnolia officinalis resources, but also produce greater economic and social benefits. The income increase of drug farmers and pharmaceutical farmers also played a certain supporting role.
现代分析化学研究发现,厚朴叶中也含有和厚朴相同的木脂素类成分,可以作为厚朴酚及和厚朴酚的原料植物部位加以利用。现有专利报道厚朴叶中厚朴酚及和厚朴酚提取方法有有机溶剂提取法、采用温度控制曲线控制升温速度和恒温提取等。这些提取方法萃取目标物杂质过多、厚朴酚及和厚朴酚纯度较低,不适宜工业化大规模生产。Modern analytical chemistry studies have found that Magnolia officinalis leaves also contain the same lignans as Magnolia officinalis, which can be used as raw plant parts of magnolol and honokiol. Existing patents report magnolol and honokiol extraction methods in Magnolia officinalis leaves include organic solvent extraction, temperature control curve control of heating rate and constant temperature extraction. These extraction methods have too many impurities in the target substance, and the purity of magnolol and honokiol is low, so they are not suitable for large-scale industrial production.
中国专利申请CN 102304027 A公开了一种从厚朴树叶中提取厚朴酚的方法,其步骤是:1.厚朴叶粉末用甲醇浸泡24h,抽滤,重复浸取三次,滤液浓缩至浸膏;2.浸膏中加入饱和澄清石灰水,搅拌1h,离心,重复三次;3.上清液酸化至pH=2-3,搅拌30min,离心,固形物用硅胶拌合,再用石油醚加热至微沸,保温10min,热滤,溶液用无水Na2SO4干燥;4.将干燥石油醚溶液浓缩,冷却结晶,得厚朴酚产品。该方法中需要使用浓酸将上清液pH值调至2-3,且要用石油醚加热到微沸。石油醚易燃易爆,其蒸气与空气可形成爆炸性混合物,遇明火、高热能引起燃烧爆炸。这些因素增加了操作的风险性,既不利于保护劳动者,也不利于产业化实施。石油醚成本较高。Chinese patent application CN 102304027 A discloses a method for extracting magnolol from Magnolia officinalis leaves, the steps are: 1. Magnolia officinalis leaf powder is soaked in methanol for 24h, suction filtered, repeated leaching three times, and the filtrate is concentrated to an extract ;2. Add saturated and clarified lime water to the extract, stir for 1 hour, centrifuge, and repeat three times; 3. Acidify the supernatant to pH=2-3, stir for 30 minutes, centrifuge, mix the solid with silica gel, and then heat with petroleum ether Bring to a slight boil, keep warm for 10 minutes, heat filter, and dry the solution with anhydrous Na 2 SO 4 ; 4. Concentrate the dry petroleum ether solution, cool and crystallize to obtain the magnolol product. In this method, it is necessary to use concentrated acid to adjust the pH value of the supernatant to 2-3, and to use petroleum ether to heat to a slight boil. Petroleum ether is flammable and explosive, and its vapor and air can form explosive mixtures, which can cause combustion and explosion when exposed to open flames and high heat. These factors increase the risk of operation, which is not conducive to the protection of laborers, nor to the implementation of industrialization. The cost of petroleum ether is higher.
发明内容Contents of the invention
本发明的目的是针对现有产业化分离厚朴酚及和厚朴酚技术的不足,提供一种工艺设备简单、生产周期短、投资规模小、操作安全、对环境污染相对较轻、制备成本低、得率较高的高纯度厚朴酚及和厚朴酚的制备方法。The purpose of the present invention is to address the shortcomings of the existing industrialized separation of magnolol and honokiol technology, to provide a process with simple equipment, short production cycle, small investment scale, safe operation, relatively light environmental pollution, and low production cost. High-purity magnolol with low yield and high yield and a preparation method of honokiol.
本发明通过以下方法实现本发明目的:The present invention realizes object of the present invention by following method:
一种从厚朴叶中制备厚朴酚及和厚朴酚的方法,步骤如下:A method for preparing magnolol and honokiol from magnolia leaves, the steps are as follows:
(1)取干厚朴叶粉碎;(1) get dried Magnolia officinalis and pulverize;
(2)厚朴叶粉末用4~6倍量的pH值为9-10的体积百分比浓度为60-95%碱性甲醇或乙醇溶液回流提取2-3次,提取温度为60~70℃,每次回流提取0.5-3h,合并提取液,用酸调至pH值为6-7,回收溶剂得浸膏;(2) Magnolia officinalis leaf powder is reflux extracted 2-3 times with the pH value of 4~6 times of amount being 9-10 volume percentage concentration of 60-95% alkaline methanol or ethanol solution, and extraction temperature is 60~70 ℃, Reflux extraction for 0.5-3 hours each time, combine the extracts, adjust the pH value to 6-7 with acid, and recover the solvent to obtain the extract;
(3)浸膏用9~10倍量水溶解后,用1~2倍量的二氯甲烷萃取2-3次,或用氧化铝吸附富集,收集流出液,蒸干,备用;(3) After dissolving the extract with 9-10 times the amount of water, extract 2-3 times with 1-2 times the amount of dichloromethane, or use alumina to absorb and enrich, collect the effluent, evaporate to dryness, and set aside;
(4)取小孔径分离树脂加压装柱,用体积百分比浓度为35-50%的甲醇或乙醇或丙酮水溶液平衡柱子,然后将上样液缓慢滴加上样,上样完毕静置1-1.5h后依次用1~2倍量的体积百分比浓度为50%、55%、60%、65%、70%的甲醇、乙醇或丙酮水溶液加压洗脱,收集厚朴酚及和厚朴酚段洗脱液,浓缩回收溶剂,得到厚朴酚及和厚朴酚混合组分;(4) Take the small-pore separation resin and pressurize the column, balance the column with methanol or ethanol or acetone aqueous solution with a concentration of 35-50% by volume, then slowly add the sample solution dropwise, and let it stand for 1-2 hours after loading the sample. After 1.5h, use 1 to 2 times the volume percentage concentration of 50%, 55%, 60%, 65%, 70% methanol, ethanol or acetone aqueous solution to elute under pressure, and collect magnolol and honokiol Section eluate, concentrate recovery solvent, obtain magnolol and honokiol mixed component;
(5)取厚朴酚及和厚朴酚混合组分,用无水甲醇、或乙醇、或丙酮溶解,以4~6倍量的硅胶拌样,用硅胶为填料,以18~20倍量的体积比为6:1-8:1的石油醚—丙酮为洗脱剂,层析,检测,用2~4倍量的丙酮甲醇混合液结晶2次,得到厚朴酚及和厚朴酚单体。(5) Take magnolol and honokiol mixed components, dissolve with anhydrous methanol, or ethanol, or acetone, mix the sample with 4 to 6 times the amount of silica gel, use silica gel as a filler, and use 18 to 20 times the amount The volume ratio of petroleum ether-acetone is 6:1-8:1 as the eluent, chromatography, detection, crystallization twice with 2 to 4 times the amount of acetone-methanol mixture to obtain magnolol and honokiol monomer.
步骤(2)所述的碱性甲醇或乙醇溶液采用碳酸氢钠、氢氧化钠或氨水调节其pH值;用酸调至中性的酸为盐酸。The alkaline methanol or ethanol solution described in step (2) adopts sodium bicarbonate, sodium hydroxide or ammonia water to adjust its pH value; the acid adjusted to neutrality with acid is hydrochloric acid.
步骤(4)中小孔径分离树脂为Chroma-R204。本发明采用的高精细分离小孔径吸附树脂,价格便宜,孔径分布均匀,分离精度较高,且不会造成对样品的死吸附,可重复利用,洗脱溶剂成本低、上样量大。The medium and small pore separation resin in step (4) is Chroma-R204. The high-fine separation and small-pore-diameter adsorption resin adopted in the present invention is cheap, uniform in pore size distribution, high in separation precision, does not cause dead adsorption to samples, can be reused, has low cost of elution solvent, and large sample loading.
步骤(5)所述的丙酮甲醇混合溶液是丙酮和甲醇按体积比15:1混合制得。The acetone-methanol mixed solution described in step (5) is prepared by mixing acetone and methanol at a volume ratio of 15:1.
一种厚朴叶提取物,采用以下方法制备得到:A magnolia bark leaf extract is prepared by the following method:
(1)取干厚朴叶粉碎;(1) get dried Magnolia officinalis and pulverize;
(2)厚朴叶粉末用4~6倍量的pH值为9-10的体积百分比浓度为60-95%碱性甲醇或乙醇溶液回流提取2-3次,提取温度为60~70℃,每次回流提取0.5-3h,合并提取液,用酸调至pH值为6-7,回收溶剂得浸膏;(2) Magnolia officinalis leaf powder is reflux extracted 2-3 times with the pH value of 4~6 times of amount being 9-10 volume percentage concentration of 60-95% alkaline methanol or ethanol solution, and extraction temperature is 60~70 ℃, Reflux extraction for 0.5-3 hours each time, combine the extracts, adjust the pH value to 6-7 with acid, and recover the solvent to obtain the extract;
(3)浸膏用9~10倍量水溶解后,用1~2倍量的二氯甲烷萃取2-3次,或用氧化铝吸附富集,收集流出液,蒸干,备用;(3) After dissolving the extract with 9-10 times the amount of water, extract 2-3 times with 1-2 times the amount of dichloromethane, or use alumina to absorb and enrich, collect the effluent, evaporate to dryness, and set aside;
(4)取小孔径分离树脂加压装柱,用体积百分比浓度为35-50%的甲醇或乙醇或丙酮水溶液平衡柱子,然后将上样液缓慢滴加上样,上样完毕静置1-1.5h后依次用1~2倍量的体积百分比浓度为50%、55%、60%、65%、70%的甲醇、乙醇或丙酮水溶液加压洗脱,收集厚朴酚及和厚朴酚段洗脱液,浓缩回收溶剂,得到厚朴酚及和厚朴酚混合组分;(4) Take the small-pore separation resin and pressurize the column, balance the column with methanol or ethanol or acetone aqueous solution with a concentration of 35-50% by volume, then slowly add the sample solution dropwise, and let it stand for 1-2 hours after loading the sample. After 1.5h, use 1 to 2 times the volume percentage concentration of 50%, 55%, 60%, 65%, 70% methanol, ethanol or acetone aqueous solution to elute under pressure, and collect magnolol and honokiol Section eluate, concentrate recovery solvent, obtain magnolol and honokiol mixed component;
(5)取厚朴酚及和厚朴酚混合组分,用无水甲醇、或乙醇、或丙酮溶解,以4~6倍量的硅胶拌样,用硅胶为填料,以18~20倍量的体积比为6:1-8:1的石油醚—丙酮为洗脱剂,层析,检测,用2~4倍量的丙酮甲醇混合液结晶2次,得到厚朴酚及和厚朴酚单体。(5) Take magnolol and honokiol mixed components, dissolve with anhydrous methanol, or ethanol, or acetone, mix the sample with 4 to 6 times the amount of silica gel, use silica gel as a filler, and use 18 to 20 times the amount The volume ratio of petroleum ether-acetone is 6:1-8:1 as the eluent, chromatography, detection, crystallization twice with 2 to 4 times the amount of acetone-methanol mixture to obtain magnolol and honokiol monomer.
步骤(2)所述的碱性甲醇或乙醇溶液采用碳酸氢钠、氢氧化钠或氨水调节其pH值;用酸调至中性的酸为盐酸。The alkaline methanol or ethanol solution described in step (2) adopts sodium bicarbonate, sodium hydroxide or ammonia water to adjust its pH value; the acid adjusted to neutrality with acid is hydrochloric acid.
步骤(4)中小孔径分离树脂为Chroma-R204。The medium and small pore separation resin in step (4) is Chroma-R204.
步骤(5)所述的丙酮甲醇混合溶液是丙酮和甲醇按体积比15:1混合制得。The acetone-methanol mixed solution described in step (5) is prepared by mixing acetone and methanol at a volume ratio of 15:1.
所述提取物中厚朴酚及和厚朴酚的含量>98%。The content of magnolol and honokiol in the extract is >98%.
所述的厚朴叶提取物用于制备抗菌药、抗炎药、抗焦虑药、抗抑郁药、抗肿瘤药、抗衰老药药、心肌保护药或降血糖药的用途。The Magnolia officinalis extract is used to prepare antibacterial drugs, anti-inflammatory drugs, anti-anxiety drugs, antidepressants, anti-tumor drugs, anti-aging drugs, cardioprotective drugs or hypoglycemic drugs.
本发明方法的优点如下:本发明提供了以厚朴非药用部位为原料,工业化生产活性特征性成分厚朴酚及和厚朴酚的方法。厚朴酚及和厚朴酚极性较小,并且呈弱酸性,因此用高浓度的碱性醇液提取可使二者溶出率更高。将萃取物上小孔径加压分离树脂、采用不同浓度丙酮、乙醇或甲醇等为洗脱剂均能较好分离得到TLC上厚朴酚及和厚朴酚单一斑点。能有效分离开叶绿素和长链脂肪酸等杂质。高精细分离小孔径吸附树脂不会造成对样品的死吸附,其可重复利用,具有洗脱溶剂成本低、上样量大等优点。目前国内一些厂家开发的小孔径半凝胶型吸附树脂孔径分布均匀,40-100um价格较低,每公斤300元左右,分离精度较高,在一些植物的分离提取上具有国外昂贵的MCI GEL树脂系列分离功能。The advantages of the method of the invention are as follows: the invention provides a method for industrially producing magnolol and honokiol, which are active characteristic components, using the non-medicinal parts of Magnolia officinalis as raw materials. Magnolol and honokiol are less polar and weakly acidic, so extraction with a high concentration of alkaline alcohol can make the dissolution rate of the two higher. A single spot of magnolol and honokiol on TLC can be better separated by using different concentrations of acetone, ethanol or methanol as eluents on the extract to separate the resin under pressure. It can effectively separate impurities such as chlorophyll and long-chain fatty acids. The high-fine separation and small-pore-diameter adsorption resin will not cause dead adsorption to the sample, and it can be reused. It has the advantages of low cost of elution solvent and large sample loading. At present, the small-pore semi-gel type adsorption resin developed by some domestic manufacturers has uniform pore size distribution, and the price of 40-100um is relatively low, about 300 yuan per kilogram. Series separation function.
本发明方法工艺设备简单、生产周期短、投资规模小、对环境污染相对较轻、制备成本低,厚朴酚及和厚朴酚纯度高,操作简便安全,适于工业化生产。The method of the invention has simple process equipment, short production cycle, small investment scale, relatively light environmental pollution, low preparation cost, high purity of magnolol and honokiol, simple and safe operation, and is suitable for industrial production.
下面结合附图和具体实施方式对本发明做进一步说明,并非对本发明的限制,凡依照本发明公开内容所做的本领域等同替换,均属于本发明的保护范围。The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments, which are not intended to limit the present invention. All equivalent replacements in the field made according to the disclosure of the present invention belong to the protection scope of the present invention.
附图说明Description of drawings
图1为实施例1的和厚朴酚HPLC图谱Fig. 1 is the honokiol HPLC collection of patterns of embodiment 1
图2为实施例2的和厚朴酚HPLC图谱Fig. 2 is the honokiol HPLC collection of illustrative plates of embodiment 2
图3为实施例1的厚朴酚HPLC图谱Fig. 3 is the magnolol HPLC collection of patterns of embodiment 1
图4为实施例2的厚朴酚HPLC图谱Fig. 4 is the magnolol HPLC collection of illustrative plates of embodiment 2
具体实施方式Detailed ways
下面通过实施例对本发明方法作进一步详细说明,但本发明的保护范围不局限于所述内容,实施例中如无特殊说明,使用试剂为常规市售试剂,或按常规方法制得的试剂。The method of the present invention is described in further detail below by way of examples, but protection scope of the present invention is not limited to described content, if no special instructions in the examples, use reagent is routine commercially available reagent, or the reagent that makes by conventional method.
实施例1:Example 1:
1.取厚朴叶96g粉碎至粒度为40目;1. Take 96g of Magnolia officinalis leaves and grind them to a particle size of 40 mesh;
2.厚朴叶粉末用氨水调节pH值10的95%乙醇溶液回流提取三次,提取温度60℃,其中第一次500ml溶液回流提取2小时后过滤,滤渣用500ml溶液第二次回流提取1小时后过滤,滤渣用500ml溶液第三次回流提取0.5小时过滤,合并三次提取液;用盐酸调节pH值6,回收溶剂,得到粗提物(28.8g);2. Magnolia officinalis leaf powder is reflux extracted three times with ammonia water to adjust the pH value of 10 95% ethanol solution, the extraction temperature is 60 ° C, wherein the first 500ml solution is reflux extracted for 2 hours and then filtered, and the filter residue is reflux extracted for the second time with 500ml solution for 1 hour After filtering, the filter residue was refluxed for the third time with 500ml of solution and filtered for 0.5 hours, and the three extracts were combined; the pH value was adjusted to 6 with hydrochloric acid, and the solvent was recovered to obtain a crude extract (28.8g);
3.用300ml水溶解粗提物,用二氯甲烷萃取3次,每次300ml,合并二氯甲烷液,蒸干,得浸膏(14.2g);3. Dissolve the crude extract in 300ml of water, extract 3 times with dichloromethane, 300ml each time, combine the dichloromethane solution, and evaporate to dryness to obtain extract (14.2g);
4.取500g小孔径分离树脂Chroma-R204加压装柱,用体积百分比浓度为50%的丙酮水溶液平衡柱子,然后将上样液缓慢滴加上样,上样完毕静置1h后依次用500ml体积百分比浓度为50%、55%、60%、65%、70%丙酮水溶液加压洗脱(7bar),TLC鉴别收集厚朴酚及和厚朴酚段洗脱液,回收丙酮水,得到组分A(8.3g);4. Take 500g of small-pore separation resin Chroma-R204 and pressurize the column, equilibrate the column with acetone aqueous solution with a volume percentage concentration of 50%, and then slowly add the sample solution dropwise. Concentration by volume is 50%, 55%, 60%, 65%, 70% acetone aqueous solution pressurized elution (7bar), TLC distinguishes and collects magnolol and honokiol section eluate, reclaims acetone water, obtains the composition Point A (8.3g);
5.取组分A,用100ml丙酮溶解,以50g硅胶拌样,用硅胶为填料,以800ml石油醚——丙酮(8:1)洗脱,浓缩,得到组分B(2.2g)和组分C(1.8g),用7ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)和6ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)分别结晶2次,可分离纯化得到化合物1(0.24g)和化合物2(0.13g)。HPLC检测含量>98%(见图1和图3)5. Take component A, dissolve it with 100ml of acetone, mix the sample with 50g of silica gel, use silica gel as a filler, elute with 800ml of petroleum ether—acetone (8:1), concentrate to obtain component B (2.2g) and Part C (1.8g) was crystallized twice with 7ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1) and 6ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1), which could be separated Purification afforded compound 1 (0.24 g) and compound 2 (0.13 g). HPLC detection content >98% (see Figure 1 and Figure 3)
以上所得化合物单体1和化合物2,经质谱、核磁共振氢谱、碳谱测定,分别依次鉴定为:厚朴酚(Magnolol)、和厚朴酚(Honokiol)。Compound monomer 1 and compound 2 obtained above were identified as Magnolol and Honokiol respectively by mass spectrometry, H-NMR spectrum and C-NMR spectrum.
实施例2:Example 2:
1.取厚朴叶95g粉碎至粒度为40目;1. Take 95g of Magnolia officinalis leaves and crush until the particle size is 40 mesh;
2.厚朴叶粉末用氨水调节pH值9的95%乙醇溶液回流提取三次,提取温度60℃,其中第一次500ml溶液回流提取2小时后过滤,滤渣用500ml溶液第二次回流提取1小时后过滤,滤渣用500ml溶液第三次回流提取0.5小时过滤,合并三次提取液;用盐酸调节pH值6,回收溶剂,得到粗提物(28.2g);2. Magnolia officinalis leaf powder is reflux extracted three times with ammonia water to adjust the pH value of 95% ethanol solution, the extraction temperature is 60 ° C, wherein the first 500ml solution is reflux extracted for 2 hours and then filtered, and the filter residue is reflux extracted for the second time with 500ml solution for 1 hour After filtering, the filter residue was refluxed for the third time with 500ml solution and filtered for 0.5 hours, and the three extracts were combined; the pH value was adjusted to 6 with hydrochloric acid, and the solvent was recovered to obtain a crude extract (28.2g);
3.用300ml水溶解粗提物,过滤,残渣用100ml丙酮溶解,加入400ml水成混悬液,用100g氧化铝吸附富集,收集流出液,蒸干,得浸膏(13.3g);3. Dissolve the crude extract in 300ml of water, filter, dissolve the residue in 100ml of acetone, add 400ml of water to form a suspension, use 100g of alumina to absorb and enrich, collect the effluent, evaporate to dryness, and obtain an extract (13.3g);
4.取500g小孔径分离树脂Chroma-R204加压装柱,用体积百分比浓度为50%的丙酮水溶液平衡柱子,然后将上样液缓慢滴加上样,上样完毕静置1h后依次用500ml体积百分比浓度为50%、55%、60%、65%、70%丙酮水溶液加压洗脱(7bar),TLC鉴别收集厚朴酚及和厚朴酚段洗脱液,回收丙酮水,得到组分A(9.2g);4. Take 500g of small-pore separation resin Chroma-R204 and pressurize the column, equilibrate the column with acetone aqueous solution with a volume percentage concentration of 50%, and then slowly add the sample solution dropwise. Concentration by volume is 50%, 55%, 60%, 65%, 70% acetone aqueous solution pressurized elution (7bar), TLC distinguishes and collects magnolol and honokiol section eluate, reclaims acetone water, obtains the composition Point A (9.2g);
5.取组分A,用100ml丙酮溶解,以50g硅胶拌样,用硅胶为填料,以900ml石油醚——丙酮(8:1)洗脱,浓缩,得到组分B(2.4g)和组分C(1.6g),用7.5ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)和5ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)分别结晶2次,可分离纯化得到化合物1(0.73g)和化合物2(0.49g)。HPLC检测含量>98%(见图2和图4)。5. Take component A, dissolve it with 100ml of acetone, mix the sample with 50g of silica gel, use silica gel as a filler, elute with 900ml of petroleum ether—acetone (8:1), concentrate to obtain component B (2.4g) and Part C (1.6g) was crystallized twice with 7.5ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1) and 5ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1). Compound 1 (0.73g) and compound 2 (0.49g) were obtained by separation and purification. HPLC detection content > 98% (see Figure 2 and Figure 4).
以上所得化合物单体1和化合物2,经质谱、核磁共振氢谱、碳谱测定,分别依次鉴定为:厚朴酚(Magnolol)、和厚朴酚(Honokiol)。Compound monomer 1 and compound 2 obtained above were identified as Magnolol and Honokiol respectively by mass spectrometry, H-NMR spectrum and C-NMR spectrum.
实施例3:Example 3:
1.取厚朴叶98g粉碎至粒度为40目;1. Take 98g Magnolia officinalis leaves and grind them to a particle size of 40 mesh;
2.厚朴叶粉末用氨水调节pH值9的60%甲醇溶液回流提取2次,提取温度70℃,其中第一次500ml溶液回流提取3小时后过滤,滤渣用500ml溶液第二次回流提取2小时后过滤,合并两次提取液;用盐酸调节pH值7,回收溶剂,得到粗提物(29.4g);2. Magnolia officinalis leaf powder is reflux extracted twice with ammonia water to adjust the pH value of 9 60% methanol solution, the extraction temperature is 70 ° C, wherein the first 500ml solution is reflux extracted for 3 hours and then filtered, and the filter residue is reflux extracted for the second time with 500ml solution 2 Filtrate after 1 hour, combine two extracts; Regulate pH value 7 with hydrochloric acid, reclaim solvent, obtain crude extract (29.4g);
3.用300ml水溶解粗提物,用二氯甲烷萃取2次,每次300ml,合并二氯甲烷液,蒸干,得浸膏(15.2g);3. Dissolve the crude extract in 300ml of water, extract twice with dichloromethane, 300ml each time, combine the dichloromethane solution, evaporate to dryness, and obtain extract (15.2g);
4.取500g小孔径分离树脂Chroma-R204加压装柱,用体积百分比浓度为35%的甲醇水溶液平衡柱子,然后将上样液缓慢滴加上样,上样完毕静置1.5h后依次用500ml体积百分比浓度为50%、55%、60%、65%、70%甲醇水溶液加压洗脱(7bar),TLC鉴别收集厚朴酚及和厚朴酚段洗脱液,回收甲醇水,得到组分A(7.8g);4. Take 500g of small pore size separation resin Chroma-R204 and pressurize the column, equilibrate the column with methanol aqueous solution with a concentration of 35% by volume, and then slowly add the sample solution dropwise. 500ml volume percentage concentration is 50%, 55%, 60%, 65%, 70% methanol aqueous solution pressurized elution (7bar), TLC distinguishes and collects magnolol and honokiol section eluate, reclaims methanol water, obtains Component A (7.8 g);
5.取组分A,用100ml甲醇溶解,以50g硅胶拌样,用硅胶为填料,以800ml石油醚——丙酮(6:1)洗脱,浓缩,得到组分B(3.3g)和组分C(1.9g),用10ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)和6ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)分别结晶2次,可分离纯化得到化合物1(0.22g)和化合物2(0.12g)。HPLC检测含量>98%。5. Take component A, dissolve it with 100ml of methanol, mix the sample with 50g of silica gel, use silica gel as a filler, elute with 800ml of petroleum ether—acetone (6:1), concentrate to obtain component B (3.3g) and Part C (1.9g) was crystallized twice with 10ml of acetone-methanol mixture (acetone and methanol mixed at a volume ratio of 15:1) and 6ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1), which could be separated Purification afforded Compound 1 (0.22 g) and Compound 2 (0.12 g). HPLC detection content>98%.
以上所得化合物单体1和化合物2,经质谱、核磁共振氢谱、碳谱测定,分别依次鉴定为:厚朴酚(Magnolol)、和厚朴酚(Honokiol)。Compound monomer 1 and compound 2 obtained above were identified as Magnolol and Honokiol respectively by mass spectrometry, H-NMR spectrum and C-NMR spectrum.
实施例4:Example 4:
1.取厚朴叶97g粉碎至粒度为40目;1. Take 97g of Magnolia officinalis leaves and grind them to a particle size of 40 mesh;
2.厚朴叶粉末用氨水调节pH值9的70%乙醇溶液回流提取三次,提取温度65℃,其中第一次500ml溶液回流提取3小时后过滤,滤渣用500ml溶液第二次回流提取2小时后过滤,滤渣用500ml溶液第三次回流提取0.5小时过滤,合并三次提取液;用盐酸调节pH值7,回收溶剂,得到粗提物(28.7g);2. Magnolia officinalis leaf powder is reflux extracted three times with ammonia water to adjust the pH value of 9 70% ethanol solution, the extraction temperature is 65 ° C, wherein the first 500ml solution is reflux extracted for 3 hours and then filtered, and the filter residue is reflux extracted for the second time with 500ml solution for 2 hours After filtering, the filter residue was refluxed for the third time with 500ml solution and filtered for 0.5 hours, and the three extracts were combined; the pH value was adjusted to 7 with hydrochloric acid, and the solvent was recovered to obtain a crude extract (28.7g);
3.用300ml水溶解粗提物,过滤,残渣用100ml丙酮溶解,加入400ml水成混悬液,用100g氧化铝吸附富集,收集流出液,蒸干,得浸膏(13.2g);3. Dissolve the crude extract in 300ml of water, filter, dissolve the residue in 100ml of acetone, add 400ml of water to form a suspension, use 100g of alumina to absorb and enrich, collect the effluent, evaporate to dryness, and obtain an extract (13.2g);
4.取500g小孔径分离树脂Chroma-R204加压装柱,用体积百分比浓度为40%的乙醇水溶液平衡柱子,然后将上样液缓慢滴加上样,上样完毕静置1.5h后依次用500ml体积百分比浓度为50%、55%、60%、65%、70%丙酮水溶液加压洗脱(7bar),TLC鉴别收集厚朴酚及和厚朴酚段洗脱液,回收乙醇水,得到组分A(6.6g);4. Take 500g of small pore size separation resin Chroma-R204 and pressurize the column, equilibrate the column with 40% ethanol water solution by volume, then slowly add the sample solution dropwise, and then use the 500ml volume percentage concentration is 50%, 55%, 60%, 65%, 70% acetone aqueous solution pressurized elution (7bar), TLC differentiates and collects magnolol and honokiol section eluate, reclaims ethanol water, obtains Component A (6.6 g);
5.取组分A,用100ml乙醇溶解,以50g硅胶拌样,用硅胶为填料,以1000ml石油醚——丙酮(7:1)洗脱,浓缩,得到组分B(2.8g)和组分C(1.4g),用9ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)和4.5ml丙酮甲醇混合液(丙酮和甲醇按体积比15:1混合)分别结晶2次,可分离纯化得到化合物1(0.63g)和化合物2(0.21g)。HPLC检测含量>98%。5. Take component A, dissolve it with 100ml ethanol, mix the sample with 50g silica gel, use silica gel as filler, elute with 1000ml petroleum ether—acetone (7:1), concentrate to obtain component B (2.8g) and Part C (1.4g) was crystallized twice with 9ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1) and 4.5ml of acetone-methanol mixture (acetone and methanol were mixed at a volume ratio of 15:1), and Compound 1 (0.63g) and compound 2 (0.21g) were obtained by separation and purification. HPLC detection content>98%.
以上所得化合物单体1和化合物2,经质谱、核磁共振氢谱、碳谱测定,分别依次鉴定为:厚朴酚(Magnolol)、和厚朴酚(Honokiol)。Compound monomer 1 and compound 2 obtained above were identified as Magnolol and Honokiol respectively by mass spectrometry, H-NMR spectrum and C-NMR spectrum.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410386682.4A CN104163755B (en) | 2014-08-07 | 2014-08-07 | A kind of method preparing magnolol and Honokiol from Leaf of Magnolia officinalis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410386682.4A CN104163755B (en) | 2014-08-07 | 2014-08-07 | A kind of method preparing magnolol and Honokiol from Leaf of Magnolia officinalis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104163755A CN104163755A (en) | 2014-11-26 |
| CN104163755B true CN104163755B (en) | 2015-10-14 |
Family
ID=51907759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410386682.4A Active CN104163755B (en) | 2014-08-07 | 2014-08-07 | A kind of method preparing magnolol and Honokiol from Leaf of Magnolia officinalis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104163755B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107529618B (en) * | 2016-11-09 | 2020-02-07 | 中国检验检疫科学研究院 | Method for rapidly detecting phenolic compounds in washing products |
| CN108143741B (en) * | 2018-01-04 | 2020-09-18 | 中国科学院昆明植物研究所 | Application of magnolol glucoside in preparation of medicine for treating central nervous system diseases |
| CN109627147A (en) * | 2018-11-27 | 2019-04-16 | 中南民族大学 | A kind of honokiol crystal and preparation method thereof |
| CN111773367A (en) * | 2020-08-12 | 2020-10-16 | 安徽氧趣生物科技有限公司 | Compound preparation for treating animal skin diseases and preparation method thereof |
| CN117185906B (en) * | 2023-09-21 | 2024-03-19 | 云南农业大学 | Preparation method of extract for improving inhibition rate of enterococcus faecalis and streptococcus agalactiae |
| CN117338795B (en) * | 2023-10-30 | 2024-05-17 | 四川农业大学 | Honokiol sophorolipid complex and preparation method and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4757911B2 (en) * | 2005-05-30 | 2011-08-24 | コリア インスティテュート オブ オリエンタル メディシン | Mass separation of magnolol from magnolia cortex or magnolia root |
| CN101735021B (en) * | 2008-11-26 | 2013-03-06 | 湖南农业大学 | Method for separating and purifying magnolol and honokiol by HP-20 macroporous resin |
| CN102512403A (en) * | 2011-12-06 | 2012-06-27 | 中国中医科学院西苑医院 | Application of honokiol in pharmacy, and medicine used for treating type II diabetes mellitus |
| CN102924240B (en) * | 2012-11-20 | 2014-06-11 | 雅安太时生物科技有限公司 | Method for extracting total magnolol according to alcoholic-alkaline method |
-
2014
- 2014-08-07 CN CN201410386682.4A patent/CN104163755B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN104163755A (en) | 2014-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104163755B (en) | A kind of method preparing magnolol and Honokiol from Leaf of Magnolia officinalis | |
| CN101139320A (en) | Method for separating and preparing nuciferine and lotus leaf flavonoids from lotus leaf | |
| CN102924416B (en) | Method for separating and purifying monomeric compounds from ash bark | |
| CN105481711B (en) | Hydroxy-beta-sanshool monomer preparation method | |
| CN102219814A (en) | Method for extracting aucubin from eucommia ulmoides oliver seed draff | |
| CN115703740B (en) | Preparation method of bulleyaconitine A | |
| CN107513086B (en) | Method for extracting and separating high-purity scutellarin from scutellaria baicalensis stem and leaf and scutellarin | |
| CN110655453A (en) | Extraction and separation method of hypocannabidiol | |
| CN111039914A (en) | Extraction and separation method of cannabinol | |
| US20130231469A1 (en) | Method for preparing albiflorin and paeoniflorin | |
| CN107118219B (en) | The method of separating-purifying gelsevirine, koumidine, koumine, gelsemine and furans koumine from elegant jessamine | |
| CN106632542B (en) | Preparation method of cimicidin glycoside and 5-O-methylvisammioside reference substance | |
| CN105669797A (en) | Method for separating burdock oil, arctiin, arctigenin, lappaol E and lappaol H from burdock | |
| CN102432420B (en) | Method for extracting and separating beta-elemene from Lantana camara | |
| CN111171104B (en) | Method for preparing ursolic acid from rosemary oil paste by-product | |
| CN101747406A (en) | Technology for producing triptodiolide with leaf of tripterygium | |
| CN106699819A (en) | Preparation method for pentagalloylglucose chemical reference substance | |
| CN114426478B (en) | A high-content gallic acid and its preparation method | |
| CN104311615B (en) | Method for extracting and separating hyperoside and gossypetin-3-O-beta-D-galactoside from rhododendron przewalskii maxim. leaves | |
| CN101139378A (en) | A method for extracting calycosin-7-O-β-D-glucoside from Radix Astragali | |
| CN102327310B (en) | Preparation method of high-purity platycodon root total saponin | |
| CN102659740A (en) | Method for extracting quercetin from eucommia leaves | |
| CN101613384B (en) | Dihydroxyphenethyl alcohol glycoside compound and preparation method thereof | |
| CN113831380A (en) | Preparation process of ginsenoside Re and ginsenoside Rg1 | |
| CN108191933B (en) | A kind of method for preparing new astilbin using tuckahoe as raw material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20180108 Address after: No. 1000, Second Ring East Road, Guandu District, Kunming, Yunnan Patentee after: Kunming Quanxin Biological Pharmaceutical Co., Ltd. Address before: 650500 Yunnan city of Kunming province Chenggong City Yuhua Road No. 1076 Patentee before: Yunnan University of Traditional Chinese Medicine |
|
| TR01 | Transfer of patent right | ||
| CP03 | Change of name, title or address |
Address after: 650000 Jinma Temple, Eastern Suburb of Kunming City, Yunnan Province (next to Jinzhai District, opposite Kunming Prison) Patentee after: Kunming Ziyugong Quanxin Biopharmaceutical Co., Ltd. Address before: 650216 No. 1000 East Second Ring Road, Guandu District, Kunming City, Yunnan Province Patentee before: Kunming Quanxin Biological Pharmaceutical Co., Ltd. |
|
| CP03 | Change of name, title or address | ||
| CP02 | Change in the address of a patent holder |
Address after: No.2, longshun street, Lufu sub district office, Shilin Yi Autonomous County, Kunming City, Yunnan Province Patentee after: Kunming Ziyugong Quanxin Biopharmaceutical Co.,Ltd. Address before: 650000 Jinma Temple, Eastern Suburb of Kunming City, Yunnan Province (next to Jinzhai District, opposite Kunming Prison) Patentee before: Kunming Ziyugong Quanxin Biopharmaceutical Co.,Ltd. |
|
| CP02 | Change in the address of a patent holder |